Tripathi Manasi, Rao Siddhartha, Sinha Rajesh
Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India.
Indian J Ophthalmol. 2025 Jul 1;73(7):933-945. doi: 10.4103/IJO.IJO_2812_24. Epub 2025 Jun 30.
Scleral-fixated intraocular lenses (SFIOLs) have emerged as a vital option for visual rehabilitation of aphakia in cases where capsular support is inadequate or absent. Although alternative methods such as anterior chamber IOLs (ACIOLs) and iris-claw lenses may also be employed in such scenarios, SFIOLs are particularly suitable for eyes with low endothelial cell counts, shallow anterior chambers, iris abnormalities, or aniridia. First introduced by Malbran et al., SFIOL techniques have evolved significantly, with numerous modifications and innovations contributed by surgeons worldwide. This article comprehensively reviews the current evidence surrounding SFIOL implantation, including advancements in surgical methods, complications, and long-term outcomes. It highlights emerging trends such as sutureless techniques, improved lens designs, and minimally invasive approaches that enhance safety and efficacy and the application of SFIOLs in complex clinical scenarios.
巩膜固定人工晶状体(SFIOLs)已成为在囊袋支撑不足或缺失的情况下无晶状体眼视觉康复的重要选择。尽管在这种情况下也可采用其他方法,如前房人工晶状体(ACIOLs)和虹膜爪状晶状体,但SFIOLs特别适用于内皮细胞计数低、前房浅、虹膜异常或无虹膜的眼睛。SFIOL技术最初由马尔布兰等人引入,此后有了显著发展,全球外科医生做出了众多改进和创新。本文全面回顾了围绕SFIOL植入的当前证据,包括手术方法的进展、并发症和长期结果。它强调了诸如无缝合技术、改进的晶状体设计和微创方法等新趋势,这些趋势提高了安全性和有效性,以及SFIOLs在复杂临床场景中的应用。